David B. Nash's most recent trade in ANI Pharmaceuticals Inc was a trade of 6,865 Common Stock done . Disclosure was reported to the exchange on May 23, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| ANI Pharmaceuticals Inc | David B. Nash | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2023 | 6,865 | 38,561 (0%) | 0% | 0 | Common Stock | |
| ANI Pharmaceuticals Inc | David B. Nash | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Apr 2022 | 10,049 | 31,696 (0%) | 0% | 0 | Common Stock | |
| ANI Pharmaceuticals Inc | David B. Nash | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Mar 2021 | 9,292 | 21,647 (0%) | 0% | 0 | Common Stock |